Skip to main content Skip to footer

Baylor Scott & White Liver Consultants of Texas Dallas

Baylor Scott & White Liver Consultants of Texas

Location notice
Effective May 2, 2022 our Fort Worth location will be temporarily moving suites due to renovations. As of May 2, our new location will be 1250 8th Ave, Ste 650, Fort Worth, TX 76104. Please call our office if you have any questions.

Baylor Scott & White Liver Consultants of Texas doctors group photo

Liver specialists in Dallas, Fort Worth and Plano provide comprehensive liver disease diagnosis and advanced treatment

Baylor Scott & White Liver Consultants of Texas provides premiere liver disease diagnosis and treatment of all liver disorders including liver cancer and liver disease that may require a transplant.

With 15 hepatologists on staff at Baylor University Medical Center, part of Baylor Scott & White Health and Baylor Scott & White All Saints Medical Center - Fort Worth, BSW Liver Consultants of Texas encompasses one of the most comprehensive and experienced liver disease practices in the nation.

Our 12 liver outreach clinics located throughout Texas, bring specialized liver care to patients closer to home. Our hepatologists travel to the outreach clinics as often as three times a month to see patients with viral hepatitis, cirrhosis, liver masses and other general liver conditions.


{{CurrentLocationName}} is a part of {{p.groupName}} which has {{OtherLocationCount}} locations. Select a location above for more details. has {{OtherLocationCount}} locations. Select a location above for more details. no locations listed.

{{p.groupName}} has {{OtherLocationCount}} locations. Select a location above for more details. no locations listed. Select a location above for more details. No locations currently listed.

Tools & Resources

Our services are designed with you in mind so managing your healthcare needs is as simple as possible.

  • Patient Forms
  • Patient Resources
  • MyBSWHealth
  • Pay Your Bill
  • Financial Assistance
  • Accepted Insurance

Patient Forms

To ensure your visit to our office is as efficient as possible, complete the registration form before you arrive. You may complete it electronically, print the form at home and bring it with you to your office visit.

New Patient Registration Forms

Physician Referral Form

Authorization Forms

We do not release your medical information without your authorization.

Patient Resources

​​Patient Resources

For patients seeking more information or treatment, we recommend the following online resources:


MyBSWHealth is an online tool where you can communicate with your providers, schedule an appointment, access and manage your family’s health.

Pay Your Bill

We offer an easy, secure way to pay your HTPN bill online through MyBSWHealth.

Financial Assistance

At Baylor Scott & White Health, we want to be a resource for you and your family. Our team of financial counselors is here to help. We encourage you to speak to a member of our team at any time—before, during or after care is received.

Accepted Insurance

Baylor Scott & White has established agreements with several types of insurances in an effort to make sure your health needs are covered.

Medical Conditions

Baylor Scott & White Liver Consultants of Texas offers expertise and treatment options conveniently located near you.

  • Acute Liver Failure
  • Alcohol-related Liver Disease
  • Alpha-1-Antitrypsin Deficiency
  • Amyloidosis
  • Ascites
  • Cholangiocarcinoma
  • Cirrhosis
  • Fatty liver disease
  • Hemochromatosis
  • Hepatitis
  • Liver Cancer
  • Liver Disease
  • Nonalcoholic Fatty Liver Disease
  • Portal Vein Thrombosis
  • Primary Biliary Cholangitis (PBC)
  • Primary Sclerosing Cholangitis (PSC)
  • Toxic (Drug-induced) Liver Injury
  • Varices
  • Wilson’s Disease

Acute Liver Failure

A condition in which the liver is unable to perform its normal metabolic functions. Liver failure is often triggered due to an overdose of acetaminophen, infections or because of prescription drugs. It happens in patients without long-term liver disease. The liver quits working within a very short time – within days or weeks.

Alcohol-related Liver Disease

Inflammation of the liver caused by chronic heavy drinking of alcohol. Alcohol is the second most common cause of liver cirrhosis.

Alpha-1-Antitrypsin Deficiency

A hereditary genetic disorder that may lead to the development of liver or lung disease.


A disease in which abnormal proteins, known as amyloid fibrils, build up in tissue. There are several types with varying symptoms; including diarrhea, weight loss, fatigue, bleeding, numbness, swelling of the legs, or enlargement of the spleen.


Abnormal accumulation of fluid in the abdomen typically caused by chronic liver disease. Autoimmune hepatitis – A disease in which the body’s own immune system attacks the liver and causes it to become inflamed. The chronic disease if untreated, can lead to cirrhosis and liver failure.


Also called bile duct cancer because it begins in the bile duct, which carries bile and digestive fluid through the liver.


A degenerative disease of the liver resulting in scarring and liver failure most often caused by hepatitis, alcohol-related liver disease and non-alcoholic fatty liver disease.

Fatty liver disease

Excessive build-up of fat in the liver


An inherited condition in which the body absorbs and stores too much iron. The extra iron can build up in the liver and cause serious damage. Without treatment, the liver can fail.


A viral infection that causes inflammation of the liver.

Liver Cancer

The growth and spread of unhealthy cells in the liver. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is about twice as common in men than in women.

Liver Disease

Our hepatologists work with patients, families and colleagues in multiple fields to prevent, diagnose, treat and manage complications of liver disease. Treatment options depend on your liver disease diagnosis. Some liver diseases can be treated with medication or outpatient procedures, while others may require surgery or a liver transplant.

Nonalcoholic Fatty Liver Disease

NAFLD is excessive fat buildup in the liver without another clear cause such as alcohol use. There are two types: non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH). NASH also includes liver inflammation.

Portal Vein Thrombosis

A blockage or narrowing of the blood vessel that brings blood to the liver from the intestines.

Primary Biliary Cholangitis (PBC)

A chronic liver disease resulting from progressive destruction of the bile ducts in the liver. When the ducts are destroyed, bile builds up in the liver contributing to inflammation and scarring (fibrosis) which can eventually lead to cirrhosis.

Primary Sclerosing Cholangitis (PSC)

A slow progressing chronic disease that scars the bile ducts and can eventually block them. The bile builds up in the liver and makes it harder for the liver to work. The condition may lead to liver cancer.

Toxic (Drug-induced) Liver Injury

An uncommon but potentially fatal cause of liver disease associated with prescription medications, over-the-counter drugs, and herbal and dietary supplements.


Abnormal, enlarged veins in the esophagus. Commonly occurs when blood flow to the liver is blocked by a clot or scar tissue in the liver.

Wilson’s Disease

An inherited condition that causes the body to retain excess copper in the liver. If untreated, Wilson’s disease can cause liver failure and brain damage.

  • Participate in a clinical trial

    More than 40 drug trials designed to treat or cure the hepatitis C virus are currently underway at Baylor Dallas and Baylor Fort Worth.

Research and News

New Medicine Could Melt Away Fat

A new therapy that could revolutionize how fatty liver disease is managed.

James Trotter, MD, Medical Director, Transplant Hepatology at Baylor University Medical Center is one of the chief investigators of a new therapy that could revolutionize how fatty liver disease is managed. According to the American Liver Foundation, 60 million Americans are living with nonalcoholic steatohepatitis (NASH) which is a part of a group of conditions that lead to fat buildup in the liver, inflammation and fibrosis. Early results were just published in The Lancet, one of the highest ranked medicine journals in the world.

Reducing barriers to living donor transplantation

This pilot study aims to determine how living donor transplant candidates fare after transplant. Data collection began in April 2018 and will continue over the next two years to provide people considering donating more detailed information about the long-term benefits and risks of living donation.

Baylor University Medical Center is one of 16 sites nationwide participating in a pilot study to determine how living donor transplant candidates fare after transplant, whether they actually donate or not. There are six liver transplant sites, including Baylor, and ten kidney programs participating in the study. The need for solid organ transplants is still growing but living donor transplants have actually declined from their peak in 2004. One of the major barriers to living organ donation is that long-term outcomes for donors are unclear. The Scientific Registry of Transplant Recipients (SRTR) has now launched the Living Donor Collective (LDC) to establish a living donor registry to study the long-term outcomes of living organ donation.

The goal of the project is to establish a living organ donor registry where all living donor candidates who are evaluated will be entered into a database. All aspects of their physical and psychosocial well-being will be tracked. The (LDC) will follow up approximately one year after the transplant surgery or a year after the decision not to donate. Donors and non-donors will be followed to monitor long-term outcomes of both groups. Ultimately, the research collected over the next two years will provide people considering donating more detailed information about the long-term benefits and risks of living donation.

Infected organ saves life of Tarrant County woman

In the wake of the opioid crisis, more donated organs are infected with the hepatitis C virus and many are declined as a result. But a Tarrant County woman says she's proof that.

Global Burden of Alcohol-Related Liver Disease is Trending Upward

Read article

Mortality Rate for Chronic Liver Disease Underestimated

Read article

Dr. Sumeet Asrani discusses liver health

Watch the interview

Scroll To Top